BaroFold, Inc. and Lonza Inc. Announce a Technology Evaluation Agreement for PreEMT™, a High Pressure Protein Refolding Technology
1/16/2013 9:12:19 AM
More...
|
BaroFold, Inc. and Boehringer Ingelheim Corporation Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology
11/13/2012 8:14:09 AM
More...
|
BaroFold, Inc. Grants Exclusive License for Interferon Beta Products Developed Using PreEMT(TM) Technology to Nuron Biotech
5/17/2010 9:21:03 AM
More...
|
BaroFold, Inc. Appoints J. William Freytag, Ph.D. as President and Chief Executive Officer
1/28/2009 6:18:12 AM
More...
|
BaroFold, Inc. Initiates First Human Studies for Multiple Sclerosis Drug Candidate, BaroFeron™
6/16/2008 1:15:49 PM
More...
|
Jon S. Saxe Appointed to Board of Directors of BaroFold, Inc.
4/16/2008 8:38:29 AM
More...
|
BaroFold, Inc. and Avecia Announce Development and Manufacturing Agreement
10/9/2007 8:25:36 AM
More...
|
BaroFold, Inc. (Jobs) to Raise $12 Million in Private Placement
5/24/2007 9:28:08 AM
More...
|
BaroFold, Inc. to Present at C21 BioVentures Conference
5/18/2007 12:02:43 PM
More...
|
BaroFold, Inc. CEO to Chair Panel Regarding Biologics and Drug Development Challenges: 'Novel Approaches to Protein Aggregation and Production' at the Biotechnology Industry Organization (BIO) International Conference
5/7/2007 2:25:41 PM
More...
|
|